MHSAL Guidelines for the Prevention and Control of Antimicrobial Resistant Organisms (AROs) - Response to Questions

Similar documents
NONFERMENTING GRAM NEGATIVE RODS. April Abbott Deaconess Health System Evansville, IN

Public Health Surveillance for Multi Drug Resistant Organisms in Orange County

Detecting Carbapenemase-Producing Enterobacteriaceae: why isn t there a single best method?

In-House Standardization of Carba NP Test for Carbapenemase Detection in Gram Negative Bacteria

Educational Workshops 2016

The role of an AMR reference laboratory

Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011

CRO and CPE: Epidemiology and diagnostic tests

Detection of Carbapenem Resistant Enterobacteriacae from Clinical Isolates

Spread of carbapenems resistant Enterobacteriaceae in South Africa; report from National Antimicrobial Resistance Reference Laboratory

Standardisation of testing for Carbapenemase Producing Organisms (CPO) in Scotland

Screening and detection of carbapenemases

ORIGINAL ARTICLE. Julie Creighton and Clare Tibbs. Canterbury Health Laboratories, Christchurch

Determining the Optimal Carbapenem MIC that Distinguishes Carbapenemase-Producing

β CARBA Test Rapid detection of carbapenemase-producing Enterobacteriaceae strains Contents 1. INTENDED USE

Detecting CRE. what does one need to do?

ALERT. Clinical microbiology considerations related to the emergence of. New Delhi metallo beta lactamases (NDM 1) and Klebsiella

Rapid identification of emerging resistance in Gram negatives. Prof. Patrice Nordmann

Appendix B: Provincial Case Definitions for Reportable Diseases

Phenotypic detection of ESBLs and carbapenemases

Enterobacteriaceae with acquired carbapenemases, 2016

Carbapenemases in Enterobacteriaceae: Prof P. Nordmann Bicêtre hospital, South-Paris Med School

Evaluation of CHROMagar msupercarba for the detection of carbapenemaseproducing Gram-negative organisms

Scottish Microbiology and Virology Network. Carbapenemase producers: screening and the new Scottish AMR Satellite Reference Laboratory Service

Infection Control Strategies to Avoid Carbapenam Resistance in Hospitals. Victor Lim International Medical University Malaysia

Evaluation of Six Phenotypic Methods for the Detection of Carbapenemases in Gram-Negative Bacteria With Characterized Resistance Mechanisms

Toolkit for the Management of Carbapenemase Producing Organisms (CPO)

Nightmare Bacteria. Disclosures. Technician Objectives. Pharmacist Objectives. Carbapenem Resistance in Carbapenem Resistance in 2017

The Public Health Benefit of CRE Colonization Testing

Differentiation of Carbapenemase producing Enterobacteriaceae by Triple disc Test

Regional Emergence of VIM producing carbapenem resistant Pseudomonas aeruginosa (VIM CRPA)

Noelisa Montero, MPH. Epidemiologist Consultant. October 19, 2017 Connecticut Department of Public Health Healthcare Associated Infections Program

Canadian Nosocomial Infection Surveillance Program (CNISP)

The Antibiotic Resistance Laboratory Network

CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE

Enterobacteriaceae? ECDC EVIDENCE BRIEF. Why focus on. Update on the spread of carbapenemase-producing Enterobacteriaceae in Europe

Received 31 January 2011/Returned for modification 2 March 2011/Accepted 15 March 2011

North Carolina CRE Laboratory Task Force

Insert for Kit 98006/98010/ KPC/Metallo-B-Lactamase Confirm Kit KPC+MBL detection Kit KPC/MBL and OXA-48 Confirm Kit REVISION: DBV0034J

Academic Perspective in. David Livermore Prof of Medical Microbiology, UEA Lead on Antibiotic resistance PHE

Laboratory testing for carbapenems resistant Enterobacteriacae (CRE)

Emerging Superbugs. Mark D. Gonzalez, PhD D(ABMM) Children s Healthcare of Atlanta September 7,2018. No financial disclosures

Multidrug-resistant organisms are a major public health

Original Article Clinical Microbiology

Validating a selection method for. H. Hasman, Y. Agersø, C. Svendsen, H. Nielsen, N.S. Jensen, B. Guerra, Aarestrup, FM

Impact of the isolation medium for detection of carbapenemase-producing Enterobacteriaceae using an updated version of the Carba NP test

Recommendations for the Management of Carbapenem- Resistant Enterobacteriaceae (CRE) in Acute and Long-term Acute Care Hospitals

Rapid detection of carbapenemase-producing Pseudomonas spp.

Sensitive and specific Modified Hodge Test for KPC and metallo-beta-lactamase

2612 Page. *Yusuf, I 1., Rabiu A.T 1., Haruna, M 2. and Abdullahi, S. A 3. Phone:

JMSCR Vol 05 Issue 03 Page March 2017

Carbapenemase-producing Enterobacteriaceae

In Vitro Activity of Ceftazidime-Avibactam Against Isolates. in a Phase 3 Open-label Clinical Trial for Complicated

Resistance to Polymyxins in France

Enterobacteriaceae with acquired carbapenemases, 2015

Antibiotic Treatment of GNR MDR Infections. Stan Deresinski

National Center for Emerging and Zoonotic Infectious Diseases The Biggest Antibiotic Resistance Threats

Carbapenems and Enterobacteriaceae

Carbapenem Disks on MacConkey agar as screening methods for the detection of. Carbapenem-Resistant Gram negative rods in stools.

Burns outbreaks - the UHB experience

Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories

AAC Accepts, published online ahead of print on 13 October 2008 Antimicrob. Agents Chemother. doi: /aac

CRE Laboratory Detection & Recap of ARO Consensus Conference

Strains characterization Testing procedure of commercial carbapenemase detection assays

Emergence of non-kpc carbapenemases: NDM and more

New Mechanisms of Antimicrobial Resistance and Methods for Carbapenemase Detection

Laboratory CLSI M100-S18 update. Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator

Mechanisms of Resistance to Ceftazidime-Avibactam. Romney M. Humphries, PhD D(ABMM) Chief Scientific Officer Accelerate Diagnostics.

Phenotypic Detection Methods of Carbapenemase Production in Enterobacteriaceae

Rapid detection of carbapenemase-producing Enterobacteriaceae from blood cultures

Revised AAC Short Form format. Comparison of two phenotypic algorithms to detect carbapenemaseproducing

Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae in Taiwan

Diagnosis of CPE: time to throw away those agar plates? Jon Otter, PhD FRCPath Guy s and St. Thomas NHS Foundation Trust / King s College London

Sensitivity of Surveillance Testing for Multidrug-Resistant Gram-Negative Bacteria in the

10/4/16. mcr-1. Emerging Resistance Updates. Objectives. National Center for Emerging and Zoonotic Infectious Diseases. Alex Kallen, MD, MPH, FACP

Carbapenem-resistant Enterobacteriaceae (CRE): Coming to a hospital near you?

Abstract. Introduction. Editor: R. Canton

Carbapenemase Producing Organisms. Manal Tadros Medical Microbiologist Fraser Health Authority

Carbapenem resistance has emerged worldwide in clinical isolates of Enterobacteriaceae. crossm

Update on CLSI and EUCAST

Abstract. Introduction. Methods. Editor: R. Canton

Discussion points CLSI M100 S19 Update. #1 format of tables has changed. #2 non susceptible category

ANTIMICROBIAL RESISTANT ORGANISMS (ARO) SURVEILLANCE

Burns outbreaks - the UHB experience

Below is an overview of the oral and poster presentations featuring cefiderocol and S at IDWeek 2017:

β-lactamase inhibitors

Ceftazidime-Avibactam and Aztreonam an interesting strategy to Overcome β- Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae

Detection of resistance mechanisms using Neo- Sensitabs and Diatabs. Detection of beta lactamases. Carbapenemases and phenotypic methods for detection

Evaluation of the in vitro activity of ceftazidime-avibactam and ceftolozane-tazobactam

Navigating Through Current and Emerging Issues in Outbreaks

HOW BUGS COMBAT DRUGS: ANTIMICROBIAL RESISTANCE MECHANISMS IN THE MODERN ERA. Romney Humphries, PhD D(ABMM)

Nature and Science 2017;15(10)

Positive for carbapenemase production by a phenotypic method

Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital

R EVIEWS OF T HERAPEUTICS

Frequency of Occurrence and Antimicrobial Susceptibility of Bacteria from ICU Patients with Pneumonia

High Stringency Evaluation of the Automated BD Phoenix CPO Detect and. Running Title: Phenotypic Carbapenemase Detection and Classification

Screening of Carbapenem Resistant Enterobacteriaceae among Nosocomial Isolates: A Study from South India

First Clinical Cases of OXA-48 Producing Carbapenem Resistant Klebsiella pneumoniae in

PROFESSOR PETER M. HAWKEY

Transcription:

MHSAL Guidelines for the Prevention and Control of Antimicrobial Resistant Organisms (AROs) - Response to Questions Dr. Andrew Walkty Medical Microbiologist, Diagnostic Services Manitoba (DSM) June. 17, 2016

Question: What is the difference between CRE and CPO?

Definitions Carbapenem-resistant organism (CRO): Gram-negative bacilli that test non-susceptible (as defined by CLSI) to one or more carbapenem antimicrobials Includes Enterobacteriaceae and non-enterobacteriaceae (e.g., Acinetobacter, Pseudomonas aeruginosa) May or may not be due to a carbapenemase Carbapenemase-producing organism (CPO): Gram-negative bacteria that produce a carbapenemase enzyme. The term CPO includes Enterobacteriaceae that produce a carbapenemase (CPE), as well as other carbapenemase-producing non- Enterobacteriaceae such as Pseudomonas aeruginosa and Acinetobacter baumannii. Most CPO isolates demonstrate phenotypic resistance to carbapenems.

Definitions Carbapenem-resistant Enterobacteriaceae (CRE): Gram-negative bacteria in the family Enterobacteriaceae that that test non-susceptible (as defined by CLSI) to one or more carbapenem antimicrobials. NB. Phenotypic resistance to carbapenems may result from the production of a carbapenemase enzyme or from other mechanisms (e.g., permeability changes, efflux, etc.). Carbapenemase-producing Enterobacteriaceae (CPE): Gram-negative bacteria in the family Enterobacteriaceae that produce a carbapenemase enzyme. Most CPE isolates demonstrate phenotypic resistance to carbapenems and would therefore also meet the definition of CRE.

Laboratory Protocol Phenotypic resistance to carbapenems is determined with routine susceptibility testing methods (VITEK, disk diffusion, E-test, etc ) For Enterobacteriaceae that demonstrate reduced carbapenem susceptibility, a phenotypic test for carbapenemase production is performed (Neo-Rapid CARB Kit carba NP test) Isolates positive for carbapenemase production get a molecular test for common carbapenemase genes

Example 1: Supplemental testing: carba NP test POSITIVE, PCR demonstrates the presence of NDM-1

Example 1: This Klebsiella isolate demonstrates resistance to carbapenems by routine susceptibility testing, hence, by definition it is a carbapenem-resistant Enterobacteriaceae (CRE) The carba NP test is positive indicating the isolate produces a carbapenemase enzyme, hence it is also a carbapenemase-producing Enterobacteriaceae (CPE) The enzyme here is the NDM enzyme a metallo beta-lactamase (Ambler Class B)

Example 2. Supplemental testing: carba NP test POSITIVE, PCR demonstrates the presence of OXA-48

Example 2. This E. coli isolate demonstrates resistance to carbapenems by routine susceptibility testing, hence, by definition it is a carbapenem-resistant Enterobacteriaceae (CRE) The carba NP test is positive indicating the isolate produces a carbapenemase enzyme, hence it is also a carbapenemase-producing Enterobacteriaceae (CPE) The enzyme here is the OXA-48 enzyme a serine beta-lactamase (Ambler Class D)

Example 3: Supplemental testing: carba NP test NEGATIVE

Example 3: This Enterobacter isolate demonstrates resistance to carbapenems by routine susceptibility testing, hence, by definition it is a carbapenem-resistant Enterobacteriaceae (CRE) The carba NP test is negative, indicating the isolate does NOT produce a carbapenemase enzyme it is NOT a CPE The mechanism of reduced carbapenem susceptibility here is likely AmpC hyperproduction in combination with reduced permeability

Example 4. Supplemental testing: carba NP test POSITIVE, PCR demonstrates the presence of VIM

Example 4. This Pseudomonas isolate demonstrates resistance to carbapenems by routine susceptibility testing, hence, by definition it is a carbapenem-resistant organism (CRO) Not a member of the family Enterobacteriaceae, therefore NOT CRE The carba NP test is positive indicating the isolate produces a carbapenemase enzyme, hence it is also a carbapenemaseproducing organism (CPO) Not a member of the family Enterobacteriaceae, therefore NOT CPE The enzyme here is the VIM enzyme a metallo beta-lactamase (Ambler Class B) NB. the lab does NOT routinely look for carbapenemase production in non-enterobacteriaceae (e.g., Pseudomonas)